首页 > 最新文献

Frontiers in Cardiovascular Medicine最新文献

英文 中文
Clinical effect of vein of Marshall ethanol infusion on mitral isthmus ablation 马歇尔静脉乙醇输注对二尖瓣峡部消融术的临床效果
Pub Date : 2024-02-05 DOI: 10.3389/fcvm.2024.1253554
Weili Ge, Yi-Fei Lu, Tao Li, Ye Wang, Jie Yin, Xin-Ran Li, Jian-Jun Jiang, Ya-Fei Mi, Tao-Hsin Tung, Su-Hua Yan
This study aimed to investigate the effect of Marshall ethanol infusion (VOM-Et) in the vein on mitral isthmus (MI) ablation.Patients with persistent atrial fibrillation (AF) were grouped into vein of VOM-Et combined with radiofrequency (RF) ablation (VOM-Et-RF) and RF groups. The primary outcome was MI block immediate block rate after surgery. Stratified analysis was also performed for factors affecting the outcome measures.A total of 118 consecutive patients underwent AF ablation at Taizhou Hospital of Zhejiang Province from January 2018 to December 2021. Successful bidirectional perimitral block was achieved in 96% of patients in VOM-Et-RF (69 of 72) and in 76% of patients in the RF group (35 of 46) (P < 0.01). In the subgroup analysis, male sex, elder than 60 years, Left atrial diameter <55 mm, and AF duration <3 years were associated with the benefits of VOM-Et in AF Patients.The vein of Marshall ethanol infusion for catheter ablation can improve the MI block rate. Male sex, elder age, smaller Left atrial diameter and shorter AF duration may have significant benefits for VOM-Et.
本研究旨在探讨静脉输注马歇尔乙醇(VOM-Et)对二尖瓣峡部(MI)消融术的影响。持续性房颤(AF)患者被分为静脉VOM-Et联合射频(RF)消融术组(VOM-Et-RF)和射频组。主要结果是术后MI阻滞即刻阻滞率。2018年1月至2021年12月,共有118名连续患者在浙江省台州医院接受了房颤消融术。VOM-Et-RF组96%的患者(72例中的69例)和RF组76%的患者(46例中的35例)获得了成功的双向窦周阻滞(P<0.01)。在亚组分析中,男性、60 岁以上、左心房直径小于 55 毫米、房颤持续时间小于 3 年与房颤患者使用 VOM-Et 的益处相关。男性、高龄、较小的左心房直径和较短的房颤持续时间可能对 VOM-Et 有明显的益处。
{"title":"Clinical effect of vein of Marshall ethanol infusion on mitral isthmus ablation","authors":"Weili Ge, Yi-Fei Lu, Tao Li, Ye Wang, Jie Yin, Xin-Ran Li, Jian-Jun Jiang, Ya-Fei Mi, Tao-Hsin Tung, Su-Hua Yan","doi":"10.3389/fcvm.2024.1253554","DOIUrl":"https://doi.org/10.3389/fcvm.2024.1253554","url":null,"abstract":"This study aimed to investigate the effect of Marshall ethanol infusion (VOM-Et) in the vein on mitral isthmus (MI) ablation.Patients with persistent atrial fibrillation (AF) were grouped into vein of VOM-Et combined with radiofrequency (RF) ablation (VOM-Et-RF) and RF groups. The primary outcome was MI block immediate block rate after surgery. Stratified analysis was also performed for factors affecting the outcome measures.A total of 118 consecutive patients underwent AF ablation at Taizhou Hospital of Zhejiang Province from January 2018 to December 2021. Successful bidirectional perimitral block was achieved in 96% of patients in VOM-Et-RF (69 of 72) and in 76% of patients in the RF group (35 of 46) (P < 0.01). In the subgroup analysis, male sex, elder than 60 years, Left atrial diameter <55 mm, and AF duration <3 years were associated with the benefits of VOM-Et in AF Patients.The vein of Marshall ethanol infusion for catheter ablation can improve the MI block rate. Male sex, elder age, smaller Left atrial diameter and shorter AF duration may have significant benefits for VOM-Et.","PeriodicalId":510752,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139806068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Report: Temporary pacing using active fixation lead and invasive electrophysiology studies for immune checkpoint inhibitor associated reversible advanced atrioventricular block 病例报告:使用有源固定导联进行临时起搏和侵入性电生理学研究治疗免疫检查点抑制剂相关的可逆性晚期房室传导阻滞
Pub Date : 2024-02-05 DOI: 10.3389/fcvm.2024.1336609
Yifan Wang, Min Qian, Xiaofeng Jin, Jiaqi Wang, Tai-bo Chen, Peng Gao, Zhongwei Cheng, Jinzhi Lai, Yongtai Liu, Jingbo Fan, Lihua Zhang, Kangan Cheng, H. Deng, Quan Fang, Deyan Yang
A case of immune checkpoint inhibitors (ICIs)-associated myocarditis with reversible advanced atrioventricular block (AVB) was reported. We innovatively used active fixation lead connected to an external device for prolonged temporary pacing until atrioventricular conduction recovered. Invasive electrophysiology studies were performed to evaluate atrioventricular conduction in detail. Long-term follow-up for nearly 120-days and repeated long-term electrocardiography was conducted to ensure the conduction system was truly recovered.
报告了一例免疫检查点抑制剂(ICIs)相关心肌炎伴可逆性晚期房室传导阻滞(AVB)的病例。我们创新性地使用了与外部装置相连的有源固定导联进行长时间临时起搏,直至房室传导恢复。我们进行了有创电生理学研究,以详细评估房室传导。进行了近 120 天的长期随访和反复的长期心电图检查,以确保传导系统真正恢复。
{"title":"Case Report: Temporary pacing using active fixation lead and invasive electrophysiology studies for immune checkpoint inhibitor associated reversible advanced atrioventricular block","authors":"Yifan Wang, Min Qian, Xiaofeng Jin, Jiaqi Wang, Tai-bo Chen, Peng Gao, Zhongwei Cheng, Jinzhi Lai, Yongtai Liu, Jingbo Fan, Lihua Zhang, Kangan Cheng, H. Deng, Quan Fang, Deyan Yang","doi":"10.3389/fcvm.2024.1336609","DOIUrl":"https://doi.org/10.3389/fcvm.2024.1336609","url":null,"abstract":"A case of immune checkpoint inhibitors (ICIs)-associated myocarditis with reversible advanced atrioventricular block (AVB) was reported. We innovatively used active fixation lead connected to an external device for prolonged temporary pacing until atrioventricular conduction recovered. Invasive electrophysiology studies were performed to evaluate atrioventricular conduction in detail. Long-term follow-up for nearly 120-days and repeated long-term electrocardiography was conducted to ensure the conduction system was truly recovered.","PeriodicalId":510752,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"105 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139804521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Advanced quantitative indexes in cardiovascular magnetic resonance imaging 社论:心血管磁共振成像的高级定量指标
Pub Date : 2024-02-02 DOI: 10.3389/fcvm.2024.1302397
Xiaoyue Zhou, Yucheng Chen, Rob J. van der Geest, Peng Hu, Ming-Yen Ng
{"title":"Editorial: Advanced quantitative indexes in cardiovascular magnetic resonance imaging","authors":"Xiaoyue Zhou, Yucheng Chen, Rob J. van der Geest, Peng Hu, Ming-Yen Ng","doi":"10.3389/fcvm.2024.1302397","DOIUrl":"https://doi.org/10.3389/fcvm.2024.1302397","url":null,"abstract":"","PeriodicalId":510752,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"14 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139870845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Advanced quantitative indexes in cardiovascular magnetic resonance imaging 社论:心血管磁共振成像的高级定量指标
Pub Date : 2024-02-02 DOI: 10.3389/fcvm.2024.1302397
Xiaoyue Zhou, Yucheng Chen, Rob J. van der Geest, Peng Hu, Ming-Yen Ng
{"title":"Editorial: Advanced quantitative indexes in cardiovascular magnetic resonance imaging","authors":"Xiaoyue Zhou, Yucheng Chen, Rob J. van der Geest, Peng Hu, Ming-Yen Ng","doi":"10.3389/fcvm.2024.1302397","DOIUrl":"https://doi.org/10.3389/fcvm.2024.1302397","url":null,"abstract":"","PeriodicalId":510752,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"32 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139811142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: The wide spectrum of ventricular arrhythmias: from out-of-hospital cardiac arrest to advanced in-hospital treatment 社论:广泛的室性心律失常:从院外心脏骤停到先进的院内治疗
Pub Date : 2024-02-02 DOI: 10.3389/fcvm.2024.1361013
Enrico Baldi, Hanno L. Tan, Veronica Dusi, Roberto Rordorf, Alessandro Zorzi, S. Savastano
The wide spectrum of ventricular arrhythmias: from out-of-hospital cardiac arrest to advanced in-hospital
广泛的室性心律失常:从院外心脏骤停到先进的院内心律失常
{"title":"Editorial: The wide spectrum of ventricular arrhythmias: from out-of-hospital cardiac arrest to advanced in-hospital treatment","authors":"Enrico Baldi, Hanno L. Tan, Veronica Dusi, Roberto Rordorf, Alessandro Zorzi, S. Savastano","doi":"10.3389/fcvm.2024.1361013","DOIUrl":"https://doi.org/10.3389/fcvm.2024.1361013","url":null,"abstract":"The wide spectrum of ventricular arrhythmias: from out-of-hospital cardiac arrest to advanced in-hospital","PeriodicalId":510752,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"109 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139810391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: The wide spectrum of ventricular arrhythmias: from out-of-hospital cardiac arrest to advanced in-hospital treatment 社论:广泛的室性心律失常:从院外心脏骤停到先进的院内治疗
Pub Date : 2024-02-02 DOI: 10.3389/fcvm.2024.1361013
Enrico Baldi, Hanno L. Tan, Veronica Dusi, Roberto Rordorf, Alessandro Zorzi, S. Savastano
The wide spectrum of ventricular arrhythmias: from out-of-hospital cardiac arrest to advanced in-hospital
广泛的室性心律失常:从院外心脏骤停到先进的院内心律失常
{"title":"Editorial: The wide spectrum of ventricular arrhythmias: from out-of-hospital cardiac arrest to advanced in-hospital treatment","authors":"Enrico Baldi, Hanno L. Tan, Veronica Dusi, Roberto Rordorf, Alessandro Zorzi, S. Savastano","doi":"10.3389/fcvm.2024.1361013","DOIUrl":"https://doi.org/10.3389/fcvm.2024.1361013","url":null,"abstract":"The wide spectrum of ventricular arrhythmias: from out-of-hospital cardiac arrest to advanced in-hospital","PeriodicalId":510752,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"57 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139869903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary: The safety and efficacy of balloon-expandable vs. self-expanding trans-catheter aortic valve replacement in high-risk patients with severe symptomatic aortic stenosis 评论:严重症状性主动脉瓣狭窄高危患者接受球囊扩张与自扩张经导管主动脉瓣置换术的安全性和有效性比较
Pub Date : 2023-12-18 DOI: 10.3389/fcvm.2023.1295274
M. Reardon, Tanvir K Bajwa, J. Popma
{"title":"Commentary: The safety and efficacy of balloon-expandable vs. self-expanding trans-catheter aortic valve replacement in high-risk patients with severe symptomatic aortic stenosis","authors":"M. Reardon, Tanvir K Bajwa, J. Popma","doi":"10.3389/fcvm.2023.1295274","DOIUrl":"https://doi.org/10.3389/fcvm.2023.1295274","url":null,"abstract":"","PeriodicalId":510752,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139175860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Secular trends in the epidemiologic patterns of peripheral artery disease and risk factors in China from 1990 to 2019: Findings from the global burden of disease study 2019. 1990 - 2019年中国外周动脉疾病流行病学模式和危险因素的长期趋势:来自2019年全球疾病负担研究的结果
IF 3.6 Pub Date : 2022-09-20 eCollection Date: 2022-01-01 DOI: 10.3389/fcvm.2022.973592
Wei Gong, Shuhan Shen, Xiaojing Shi

Background: An understanding of the epidemiologic patterns of peripheral artery disease is essential in public health policy-making. We aimed to assess secular trends in the epidemiologic patterns and risk factors of peripheral artery disease from 1990 to 2019 in China.

Materials and methods: We extracted data on prevalence, incidence, death, and disability-adjusted life years (DALYs) due to peripheral artery disease from the Global Burden of Disease study 2019. In addition, risk factors for peripheral artery disease were reported.

Results: The age-standardized prevalence of peripheral artery disease significantly increased from 1330.42 to 1423.78 per 100,000 population, with an average annual percentage change (AAPC) of 0.16 [95% confidence interval (CI), 0.07 to 0.24] from 1990 to 2019 in China. In addition, the age-standardized mortality rate significantly increased, with an AAPC of 0.62 (95% CI, 0.54 to 0.7), contrasting with the significantly declining trend in age-standardized DALYs (AAPC, -0.45; 95% CI, -0.52 to -0.39) between 1990 and 2019. The age-standardized prevalence was almost three times higher in females than males [2022.13 (95% CI: 1750 to 2309.13) vs. 744.96 (95% CI: 644.62 to 850.82) per 100,000 population] in 2019. The age-specific incidence significantly increased in individuals aged 40-44, 45-49, 50-54, 55-59, and 60-64 years groups but decreased in 70-74, 75-79, and 80-84 years groups. The age and period effects showed that the relative risks of incident peripheral artery disease increased with age and time. The cohort assessment showed that the incidence decreased in successive birth cohorts. Smoking was identified as the risk factor that contributed the most to age-standardized DALYs of peripheral artery disease in 2019.

Conclusion: The burden of peripheral artery disease showed unexpected patterns that varied by age, sex, and year in China. More attention should be given to addressing the increasing incidence among middle-aged individuals and mortality among males.

背景:了解外周动脉疾病的流行病学模式对公共卫生决策至关重要。我们的目的是评估1990年至2019年中国外周动脉疾病流行病学模式和危险因素的长期趋势。材料和方法:我们从2019年全球疾病负担研究中提取了外周动脉疾病的患病率、发病率、死亡率和残疾调整生命年(DALYs)的数据。此外,外周动脉疾病的危险因素也被报道。结果:从1990年到2019年,中国外周动脉疾病的年龄标准化患病率从每10万人1330.42人显著增加到1423.78人,年均百分比变化(AAPC)为0.16[95%置信区间(CI), 0.07至0.24]。此外,年龄标准化死亡率显著增加,AAPC为0.62 (95% CI, 0.54 ~ 0.7),而年龄标准化DALYs呈显著下降趋势(AAPC, -0.45;95% CI, -0.52至-0.39)。2019年,女性的年龄标准化患病率几乎是男性的三倍[每10万人2022.13 (95% CI: 1750至2309.13)vs. 744.96 (95% CI: 644.62至850.82)]。40-44岁、45-49岁、50-54岁、55-59岁和60-64岁年龄组发病率显著增加,而70-74岁、75-79岁和80-84岁年龄组发病率下降。年龄和时期效应表明,发生外周动脉疾病的相对风险随着年龄和时间的增加而增加。队列评估显示,在连续的出生队列中,发病率下降。吸烟被确定为2019年外周动脉疾病年龄标准化DALYs的最大风险因素。结论:在中国,外周动脉疾病的负担表现出出乎意料的模式,随年龄、性别和年龄的变化而变化。应更加注意中年人发病率上升和男性死亡率上升的问题。
{"title":"Secular trends in the epidemiologic patterns of peripheral artery disease and risk factors in China from 1990 to 2019: Findings from the global burden of disease study 2019.","authors":"Wei Gong,&nbsp;Shuhan Shen,&nbsp;Xiaojing Shi","doi":"10.3389/fcvm.2022.973592","DOIUrl":"https://doi.org/10.3389/fcvm.2022.973592","url":null,"abstract":"<p><strong>Background: </strong>An understanding of the epidemiologic patterns of peripheral artery disease is essential in public health policy-making. We aimed to assess secular trends in the epidemiologic patterns and risk factors of peripheral artery disease from 1990 to 2019 in China.</p><p><strong>Materials and methods: </strong>We extracted data on prevalence, incidence, death, and disability-adjusted life years (DALYs) due to peripheral artery disease from the Global Burden of Disease study 2019. In addition, risk factors for peripheral artery disease were reported.</p><p><strong>Results: </strong>The age-standardized prevalence of peripheral artery disease significantly increased from 1330.42 to 1423.78 per 100,000 population, with an average annual percentage change (AAPC) of 0.16 [95% confidence interval (CI), 0.07 to 0.24] from 1990 to 2019 in China. In addition, the age-standardized mortality rate significantly increased, with an AAPC of 0.62 (95% CI, 0.54 to 0.7), contrasting with the significantly declining trend in age-standardized DALYs (AAPC, -0.45; 95% CI, -0.52 to -0.39) between 1990 and 2019. The age-standardized prevalence was almost three times higher in females than males [2022.13 (95% CI: 1750 to 2309.13) vs. 744.96 (95% CI: 644.62 to 850.82) per 100,000 population] in 2019. The age-specific incidence significantly increased in individuals aged 40-44, 45-49, 50-54, 55-59, and 60-64 years groups but decreased in 70-74, 75-79, and 80-84 years groups. The age and period effects showed that the relative risks of incident peripheral artery disease increased with age and time. The cohort assessment showed that the incidence decreased in successive birth cohorts. Smoking was identified as the risk factor that contributed the most to age-standardized DALYs of peripheral artery disease in 2019.</p><p><strong>Conclusion: </strong>The burden of peripheral artery disease showed unexpected patterns that varied by age, sex, and year in China. More attention should be given to addressing the increasing incidence among middle-aged individuals and mortality among males.</p>","PeriodicalId":510752,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":" ","pages":"973592"},"PeriodicalIF":3.6,"publicationDate":"2022-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33492238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between echocardiographic characteristics and cardiac biomarkers during long-distance trail running. 长距离越野跑时超声心动图特征与心脏生物标志物的关系。
IF 3.6 Pub Date : 2022-08-16 eCollection Date: 2022-01-01 DOI: 10.3389/fcvm.2022.954032
Romain Jouffroy, Hélène Hergault, Juliana Antero, Antoine Vieillard Baron, Nicolas Mansencal

Background: Even if the beneficial cardiovascular effects of moderate exercise are recognized, effects of prolonged and intense exercise are still debated. This study aims to detect cardiovascular changes associated with long endurance running by assessing the relationship between echocardiographic parameters and cardiac biomarkers during long-distance trail running.

Methods: We performed a prospective observational study that included 20 participants who were all amateur runners (median age of 41 years old, still alive after a 7-year clinical follow-up) from 80-km trail running. All the participants underwent an echocardiographic examination and venous blood sampling before the race, at the intermediate refreshment checkpoints of the race (21st and 53rd km), and within 10 min after arrival.

Results: Mitral E/A velocity ratio and mitral TDI e' wave were significantly decreased at the 21st km to arrival (p < 0.05). Mitral S wave and global longitudinal strain (GLS) were significantly decreased from the 53rd km to arrival (p < 0.05 for 53rd and 80th km). As compared to baseline, T-troponin and NT-proBNP were significantly increased at the 21st km in all the participants, but T-troponin values were systematically increased above the significative threshold. Diastolic echocardiographic abnormalities were mainly observed among participants with highest NT-proBNP (> 77 ng.l-1) values at the 21st km. As compared to baseline, mitral e' wave was significantly decreased (-35%) in participants with highest values of NT-proBNP. Similarly, GLS was also depressed among participants with highest troponin values at the 53rd km (p = 0.01 for 53rd km and p = 0.04 for arrival).

Conclusion: During the long-distance trail running, the early LV decrease in diastolic echocardiographic parameters is associated with increase in NT pro-BNP blood levels, and the decrease in LV systolic echocardiographic parameters later is associated with increase in T-troponin blood levels.

背景:即使人们认识到适度运动对心血管的有益影响,但长时间和高强度运动的影响仍存在争议。本研究旨在通过评估长距离越野跑过程中超声心动图参数与心脏生物标志物之间的关系,检测与长时间耐力跑相关的心血管变化。方法:我们进行了一项前瞻性观察研究,包括20名参加80公里越野跑的业余跑步者(中位年龄41岁,经过7年临床随访后仍然活着)。所有参赛者在赛前、比赛中间补给点(第21公里和第53公里)和到达后10分钟内均接受了超声心动图检查和静脉血采样。结果:到达21 km时,二尖瓣E/A速比和二尖瓣TDI E′波明显降低(p < 0.05)。到达第53 km时,二尖瓣S波和全球纵向应变(GLS)显著降低(第53 km和第80 km时p < 0.05)。与基线相比,所有参与者在第21公里时t -肌钙蛋白和NT-proBNP均显著升高,但t -肌钙蛋白值系统性升高至显著阈值以上。舒张超声心动图异常主要见于第21 km时NT-proBNP值最高(> 77 ng.l-1)的参与者。与基线相比,NT-proBNP值最高的受试者二尖瓣e′波显著降低(-35%)。同样,在第53公里时肌钙蛋白值最高的参与者中,GLS也被抑制(第53公里时p = 0.01,到达时p = 0.04)。结论:长距离越野跑时,早期左室舒张期超声心动图参数降低与NT - pro-BNP血水平升高有关,后期左室收缩期超声心动图参数降低与t -肌钙蛋白血水平升高有关。
{"title":"Relationship between echocardiographic characteristics and cardiac biomarkers during long-distance trail running.","authors":"Romain Jouffroy,&nbsp;Hélène Hergault,&nbsp;Juliana Antero,&nbsp;Antoine Vieillard Baron,&nbsp;Nicolas Mansencal","doi":"10.3389/fcvm.2022.954032","DOIUrl":"https://doi.org/10.3389/fcvm.2022.954032","url":null,"abstract":"<p><strong>Background: </strong>Even if the beneficial cardiovascular effects of moderate exercise are recognized, effects of prolonged and intense exercise are still debated. This study aims to detect cardiovascular changes associated with long endurance running by assessing the relationship between echocardiographic parameters and cardiac biomarkers during long-distance trail running.</p><p><strong>Methods: </strong>We performed a prospective observational study that included 20 participants who were all amateur runners (median age of 41 years old, still alive after a 7-year clinical follow-up) from 80-km trail running. All the participants underwent an echocardiographic examination and venous blood sampling before the race, at the intermediate refreshment checkpoints of the race (21st and 53rd km), and within 10 min after arrival.</p><p><strong>Results: </strong>Mitral E/A velocity ratio and mitral TDI e' wave were significantly decreased at the 21st km to arrival (<i>p</i> < 0.05). Mitral S wave and global longitudinal strain (GLS) were significantly decreased from the 53rd km to arrival (<i>p</i> < 0.05 for 53rd and 80th km). As compared to baseline, T-troponin and NT-proBNP were significantly increased at the 21st km in all the participants, but T-troponin values were systematically increased above the significative threshold. Diastolic echocardiographic abnormalities were mainly observed among participants with highest NT-proBNP (> 77 ng.l<sup>-1</sup>) values at the 21st km. As compared to baseline, mitral e' wave was significantly decreased (-35%) in participants with highest values of NT-proBNP. Similarly, GLS was also depressed among participants with highest troponin values at the 53rd km (<i>p</i> = 0.01 for 53rd km and <i>p</i> = 0.04 for arrival).</p><p><strong>Conclusion: </strong>During the long-distance trail running, the early LV decrease in diastolic echocardiographic parameters is associated with increase in NT pro-BNP blood levels, and the decrease in LV systolic echocardiographic parameters later is associated with increase in T-troponin blood levels.</p>","PeriodicalId":510752,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":" ","pages":"954032"},"PeriodicalIF":3.6,"publicationDate":"2022-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424639/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40343485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early Results of a Novel Hybrid Prosthesis for Treatment of Acute Aortic Dissection Type A With Distal Anastomosis Line Beyond Aortic Arch Zone Zero. 新型混合假体治疗主动脉弓零区远端吻合线a型急性主动脉夹层的早期结果。
IF 3.6 Pub Date : 2022-07-14 eCollection Date: 2022-01-01 DOI: 10.3389/fcvm.2022.892516
Arash Mehdiani, Yukiharu Sugimura, Louise Wollgarten, Moritz Benjamin Immohr, Sebastian Bauer, Hubert Schelzig, Markus Udo Wagenhäuser, Gerald Antoch, Artur Lichtenberg, Payam Akhyari

Introduction: Acute aortic dissection type A (AADA) is associated with high perioperative morbidity and mortality. A novel non-covered hybrid prosthesis (Ascyrus Medical Dissection Stent (AMDS) Hybrid Prosthesis, Cryolife/Jotec, Hechingen, Germany) can be easily implanted to stabilize the true lumen (TL), improve remodeling, and preserve organ perfusion. Although developed for implantation in aortic zone 0, occasionally, partial replacement of the aortic arch and further distal implantation of AMDS may appear favorable. Implantation of AMDS with anastomosis line beyond zone 0 has not been described yet.

Materials and methods: Between 08/2019 and 12/2020, a total of n = 97 patients were treated due to AADA at a single University hospital. Of those, n = 28 received an AMDS hybrid prosthesis, of whom in eight patients, due to intraoperative finding the distal anastomosis line was placed distal to the brachiocephalic trunk. Three patients had AMDS implantation in zone I and four were treated by implantation of the prostheses in zone II, and one patient had the implantation performed in zone III. Clinical outcome and the development of a proportional area of TL and false lumen (FL) at defined levels of the thoracic aorta were analyzed.

Results: None of the surviving patients (87.5%) showed signs of clinical malperfusion (i.e., stroke, spinal cord injury, and need for dialysis). A postoperative CT scan showed an open TL in all patients. The proportion of TL with respect to total aortic diameter (TL+FL) was postoperatively significantly higher in zone III (p = 0.016) and at the level of T11 (p = 0.009). The mean area of TL+FL was comparable between pre- and postoperative CT-scan (p = n.s.). One patient with preoperative resuscitation died of multiple organ failure on extracorporeal life support on postoperative day 3.

Conclusion: Implantation of AMDS can be safely performed in patients who need partial replacement of the aortic arch beyond zone 0. The advantages of the AMDS can be combined with those of the total arch repair (remodeling of the arch and prevention of TL collapse) without the possible disadvantages (risk of spinal cord injury).

急性主动脉夹层A型(AADA)是一种高围手术期发病率和死亡率的疾病。一种新型的无盖混合型假体(Ascyrus Medical Dissection Stent, AMDS), cryyolife /Jotec,德国,hehingen)可以很容易地植入,稳定真腔(TL),改善重塑,保持器官灌注。虽然AMDS是为主动脉0区植入而开发的,但偶尔,部分替代主动脉弓和进一步远端植入AMDS可能是有利的。吻合线超过0区的AMDS植入尚未见报道。材料与方法:2019年8月至2020年12月,在某大学医院因AADA接受治疗的患者共n = 97例。其中n = 28例接受AMDS混合假体,其中8例患者术中发现远端吻合线位于头臂干远端。3例患者在I区种植AMDS, 4例患者在II区种植假体,1例患者在III区种植。我们分析了临床结果和在规定的胸主动脉水平上TL和假腔(FL)的比例面积的发展。结果:存活患者(87.5%)无临床灌注不良症状(即卒中、脊髓损伤、需要透析)。术后CT扫描显示所有患者TL开放。TL占主动脉总直径(TL+FL)的比例在术后III区(p = 0.016)和T11区(p = 0.009)显著升高。TL+FL的平均面积在术前和术后ct扫描之间具有可比性(p = ns)。1例术前复苏患者术后第3天在体外生命支持下死于多器官衰竭。结论:对于0区以上主动脉弓部分置换术的患者,AMDS植入术是安全的。AMDS的优点可以与全足弓修复(弓的重塑和防止TL塌陷)相结合,而没有可能的缺点(脊髓损伤的风险)。
{"title":"Early Results of a Novel Hybrid Prosthesis for Treatment of Acute Aortic Dissection Type A With Distal Anastomosis Line Beyond Aortic Arch Zone Zero.","authors":"Arash Mehdiani,&nbsp;Yukiharu Sugimura,&nbsp;Louise Wollgarten,&nbsp;Moritz Benjamin Immohr,&nbsp;Sebastian Bauer,&nbsp;Hubert Schelzig,&nbsp;Markus Udo Wagenhäuser,&nbsp;Gerald Antoch,&nbsp;Artur Lichtenberg,&nbsp;Payam Akhyari","doi":"10.3389/fcvm.2022.892516","DOIUrl":"https://doi.org/10.3389/fcvm.2022.892516","url":null,"abstract":"<p><strong>Introduction: </strong>Acute aortic dissection type A (AADA) is associated with high perioperative morbidity and mortality. A novel non-covered hybrid prosthesis (Ascyrus Medical Dissection Stent (AMDS) Hybrid Prosthesis, Cryolife/Jotec, Hechingen, Germany) can be easily implanted to stabilize the true lumen (TL), improve remodeling, and preserve organ perfusion. Although developed for implantation in aortic zone 0, occasionally, partial replacement of the aortic arch and further distal implantation of AMDS may appear favorable. Implantation of AMDS with anastomosis line beyond zone 0 has not been described yet.</p><p><strong>Materials and methods: </strong>Between 08/2019 and 12/2020, a total of <i>n</i> = 97 patients were treated due to AADA at a single University hospital. Of those, <i>n</i> = 28 received an AMDS hybrid prosthesis, of whom in eight patients, due to intraoperative finding the distal anastomosis line was placed distal to the brachiocephalic trunk. Three patients had AMDS implantation in zone I and four were treated by implantation of the prostheses in zone II, and one patient had the implantation performed in zone III. Clinical outcome and the development of a proportional area of TL and false lumen (FL) at defined levels of the thoracic aorta were analyzed.</p><p><strong>Results: </strong>None of the surviving patients (87.5%) showed signs of clinical malperfusion (i.e., stroke, spinal cord injury, and need for dialysis). A postoperative CT scan showed an open TL in all patients. The proportion of TL with respect to total aortic diameter (TL+FL) was postoperatively significantly higher in zone III (<i>p</i> = 0.016) and at the level of T11 (<i>p</i> = 0.009). The mean area of TL+FL was comparable between pre- and postoperative CT-scan (<i>p</i> = n.s.). One patient with preoperative resuscitation died of multiple organ failure on extracorporeal life support on postoperative day 3.</p><p><strong>Conclusion: </strong>Implantation of AMDS can be safely performed in patients who need partial replacement of the aortic arch beyond zone 0. The advantages of the AMDS can be combined with those of the total arch repair (remodeling of the arch and prevention of TL collapse) without the possible disadvantages (risk of spinal cord injury).</p>","PeriodicalId":510752,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":" ","pages":"892516"},"PeriodicalIF":3.6,"publicationDate":"2022-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329696/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40661698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Frontiers in Cardiovascular Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1